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Patients with grown-up congenital heart (GUCH) disease pose a few unique problems for the 
cardiac electrophysiologist due to the myocardial substrate with high propensity for arrhythmias. 
Arrhythmias are the main reason for hospital admission in these patients and, unfortunately, in a 
significant proportion of these patients, these arrhythmic events could be life-threatening [1]. 
Furthermore,  the  onset  of  arrhythmias  may  herald  the  hemodynamic  decompensation  in  a 
sizable segment of the population with already compromised functional status. The abnormal 
circulation, in turn, may amplify the hemodynamic effect of arrhythmias in these patients with 
unrepaired or partially repaired abnormal cardiac anatomy.                                            
Previous studies into the natural history of patients with GUCH have been helpful in identifying 
the likely risk factors for arrhythmogenesis,  and the associated risk of sudden cardiac death 
(SCD) in them [2-4].  Clinical variables like older age at repair,  ventricular dysfunction, and 
need of ventriculotomy at repair  are known to adversely affect  the survival in patients with 
GUCH [2-4]. In majority, the increased arrhythmogenecity, at cellular level, is mediated by the 
co-existing  myocardial  fibrosis.  Ventricular  fibrosis  suggested  by  cardiovascular  magnetic 
resonance is known to be an important marker of poor survival in adults with repaired tetralogy 
of Fallot (TOF) [5].  Additional evidence for myocardial  fibrosis in these patients is that re-
entrant  mechanisms, as often seen with scarring,  account for majority of their arrhythmias.  
As  myocardial  scarring  can  be  taken  as  a  surrogate  marker  of  arrhythmogenesis  in  these 
patients, it is important to recognise the factors contributing to its development in them. The 
patients who had undergone ventriculotomy and / or patching for ventricular septal defects, who 
carry  the  highest  risk  of  developing ventricular  arrhythmias  in  GUCH, have  a  well-defined 
surgical  scar.  As  described  earlier  for  intraatrial-reentrant  tachyarrhythmias  associated  with 
atriotomy scars, the macro-reentrant circuits in post-ventriculotomy patients tend to use narrow 
isthmuses within the surgical scars or between the scars and anatomical barriers like valves or 
patches for its perpetuation [6]. In either of the above mechanisms, the surgical scars tend to 
determine the circuits and thereby, the targets of ablation. Zeppenfeld et al had demonstrated 
that the placement of a single ventriculotomy, outflow tract patch, or transannular patch, along 
with closure of the ventricular septal defect, would be expected to create only a limited number 
of  possible  tachycardia  circuits  [7].  However,  diffuse  or  localised  myocardial  fibrosis-  the 
second  substrate  apart  from scar  -  can  also  contribute  to  arrhythmogenesis  in  a  significant 
proportion of patients with GUCH. The abnormal hypertrophic response, chamber dilatation, 
myocardial disarray etc. could account for these additional factors in these patients with high 
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likelihood of  developing  pressure  and/or  volume overload  of  cardiac  chambers.  Myocardial 
scarring secondary to hemodynamic factors have already been described in patients with GUCH 
with  various  underlying  cardiac  anomalies  [8].  These  include  patients  with  corrected 
transposition,  Ebstein's  anomaly,  single  ventricle,  Eissenmenger's  syndrome  and  unrepaired 
TOF.
In this issue of the journal, Selvaraj et al describe a case where the circuit of the ventricular 
tachycardia  was  mapped  to  a  site  far  away  from  scar  in  a  patient  who  had  undergone 
ventriculotomy  as  a  part  of  surgical  correction  of  double-chambered  right  ventricle  [9]. 
Myocardial fibrosis, as defined by the voltage map settings, showed scar at right ventricular 
apex  in  this  case.  Due to  the  hemodynamic  instability  associated  with  the  tachycardia,  the 
authors could not perform detailed entrainment mapping techniques to delineate the circuits, and 
had to ablate based on pace mapping. Despite these limitations, the response to ablation at right 
ventricular apex was validated by the clinical response with no recurrence on follow up.  The 
authors hypothesise the prolonged exposure of right ventricular apex to high pressures could 
account for the localised scarring noted in this case.  This proposed association between this 
regional myocardial scarring unrelated to the prior ventriculotomy and the potential targets of 
successful ablation is important in an era where the hunt for the optimal targets of ablation in 
complex  arrhythmias  is  continuing.  This  is  more  relevant  in  patients  with  GUCH  and 
arrhythmia, where alternative therapeutic options are limited. The negative inotropic effects and 
safety concerns of antiarrhythmic drugs limit their wide usage, especially at high doses often 
required  to  prevent  recurrence  of  arrhythmias  in  them.  The  indications  for  implantable 
defibrillators are also not well established. Due to these concerns, though the results of catheter-
based  ablation  are  far  from  satisfactory,  electrophysiological  testing  and/or  ablation  are 
considered  as  a  worthy  option  for  symptomatic  patients  with  suspected  or  documented 
ventricular arrhythmia. Identification of these additional mechanisms of arrhythmogenesis and 
possible targets of ablation carries greater significance in this scenario.                      
The therapeutic algorithms for the management of arrhythmias tend to differ in these patients 
owing to the heterogeneity of the anatomical and physiological substrate. Despite this limitation, 
this report underscores an important fact that the arrhythmogenic substrate in congenital heart 
disease may not necessarily  be the ventriculotomy scar  alone, and the second substrate  -the 
fibrosis related to the myocardial remodelling due to chamber hypertrophy or dilatation - could 
be contributory in many. Duration of exposure of heart to the abnormal hemodynamic burden 
may be the most important factor determining the degree of remodelling and, thereby, fibrosis. 
The  higher  risk  of  SCD in TOF patients  repaired  after  20  years  of  age  have  already been 
described [3]. In a large, multicenter study, nearly 100% of patients with TOF who had their 
surgical procedure performed after 10 years of age had ventricular arrhythmias [10]. Similarly, 
electrical remodelling in atria is known to occur by adolescence in patients with atrial septal 
defects, and this has been found as a major risk factor for atrial arrhythmias in postoperative 
patients with delayed age at repair [11]. These facts clearly point towards the complementary 
role of myocardial fibrosis as an additional arrhythmogenic factor apart from surgical scar in 
these  patients.  However,  more  studies  are  required  to  identify  the  mechanisms of  complex 
electrophysiological  interaction between the scar  and this  'second substrate'  in initiation and 
perpetuation  of  these  re-entrant  arrhythmias  in  patients  with  congenital  heart  disease.
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